More Emyria Ltd news
Emyria LtdASX: EMD

Emyria Obtains TGA Approval for Medical Grade Monitoring App

May 12, 2021 at 1:45 AM EDT · Issued by Emyria Ltd

Filed with ASX · May 12, 2021 at 1:45 AM EDT

On 6ix: 6ix.com/news/emyria-obtains-tga-approval-for-medical-grade-monitoring-app

Emyria Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Emyria Ltd on 6ix

Story so far

  • Webinar on Global Partnership with Sapphire Medical ClinicsOct 21, 2020

Earlier from Emyria

  • Emyria and MMA launch MDMA-assisted therapy program for PTSDMay 4, 2021
  • $5m Placement for Drug Registration and Treatment PipelineApr 21, 2021
  • Emyria and Cann Partner to Register CBD ProductMar 28, 2021
  • Emyria Adds Second Clinical Site in PerthMar 1, 2021
  • Emyria adds second Emerald Clinic in MelbourneFeb 9, 2021

Later from Emyria

  • Emyria Data Validated, Care Model Reduces OpioidsJun 6, 2021
  • Emyria Advances EMD-004 Program Towards RegistrationJun 14, 2021
  • Emyria to Develop Novel Psychedelics Pipeline with UWAAug 4, 2021
  • Emyria Executes Pure CBD Agreement with AltaSciencesAug 12, 2021
  • Emyria Appoints Expert Neuropharmacologist for MDMA ProgramAug 19, 2021
All Emyria news releases↗

Follow Emyria into a list and get an email when it puts out news.

Follow Emyria
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer